The Keosys Blog

Keosys Jul 19, 2022

Prostate Cancer Working Group 3: Imaging Assessments Infographic

Prostate Cancer Working Group 3 (PCWG3) is an international working group of..

Keosys Jul 7, 2022

Interview: A Clinical R&D Expert Talks About the Future of Radiopharmaceuticals

With a background in clinical research and development, UK-trained physician..

Keosys Jun 28, 2022

Why are so many imaging queries sent to your site and how can you avoid them?

Why are so many imaging queries sent to your site and how can you avoid them?..

Keosys Jun 9, 2022

Heptocellular Carcinoma (HCC) Resource Page

Hepatocellular Carcinoma (HCC) is the most common cancer of the liver and the..

Keosys Jun 8, 2022

Focus On Selective Internal Radiation Therapy with HCC

This is an excerpt from our free eBook, “Hepatocellular Carcinoma and Imaging..

Keosys May 17, 2022

Evaluating Tumor Response in HCC

This is an excerpt from our free eBook, “Hepatocellular Carcinoma and Imaging..

Keosys Mar 28, 2022

Interview: An Interventional Radiologist Talks About Radioembolization in the Treatment of HCC Today

Dr. Yan Rolland, head of the diagnosis and interventional radiology department..

Keosys Mar 15, 2022

Interview: A Radiology Professor Talks About mRECIST, Reading Images in Clinical Trials, and More

Maxime Ronot, Professor at the Université de Paris, and Radiologist in the..

Keosys Feb 23, 2022

Interview: Keosys Advances into a Promising New Year

With our 20th anniversary year recently completed and a new year underway, we..

Keosys Oct 22, 2021

How to Prepare an Imaging Study While Minimizing Budget and Risk

Sometimes sponsors and CROs are not sure in the early stages of a trial that..

Keosys Sep 9, 2021

Interview: A Medical Doctor Finds Her Biotech Home

We recently spoke with Eveline Boucher, MD, Senior Medical Director for Boston..

Keosys Jul 20, 2021

Keo-Tales: Introducing the Keosys Interns

Every year, Keosys takes on a select number of interns, giving them the..

Previous All posts Next

Recent